Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-003781
Filing Date
2025-06-04
Accepted
2025-06-04 10:37:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2894
  Complete submission text file 0001959173-25-003781.txt   4864
Mailing Address C/O PACIRA BIOSCIENCES, INC. 5401 WEST KENNEDY BOULEVARD, SUITE 890 TAMPA FL 33609
Business Address
WILLIAMS KRISTEN (Reporting) CIK: 0001296965 (see all company filings)

Type: 144

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Subject) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35060 | Film No.: 251022239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)